Treatment with corticosteroids and yearly decline of forced expiratory flow (FEV1 ) in patients with severe chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Respiratory structure and function Year: 2008
Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016
Salmeterol/fluticasone therapy improves FEV1 in mild and moderate more than in severe COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 342s Year: 2004
Decline in FEV1 is faster with frequent exacerbations of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 153s Year: 2001
Decline of FEV1 in different groups of severe refractory asthmatics Source: Eur Respir J 2005; 26: Suppl. 49, 575s Year: 2005
Frequent exacerbations in COPD are associated with accelerated rate of FEV1 decline Source: Eur Respir J 2006; 28: Suppl. 50, 32s Year: 2006
Pulmonary volumes change more largely than respiratory flows in COPD patients during severe acute exacerbations Source: Eur Respir J 2005; 26: Suppl. 49, 362s Year: 2005
The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics Source: Eur Respir J 2003; 21: 95-10 Year: 2003
Correlation between spirometric indices (FEV1, FVC) and lung diffusion values (DLCO) in subjects with varying severity of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2007 - Primary care respiratory problems Year: 2007
Symptoms, but not PEF, change during an exacerbation in COPD Source: Eur Respir J 2003; 22: Suppl. 45, 238s Year: 2003
Predictors of nocturnal desaturation in COPD patients with mild daytime hypoxaemia Source: Eur Respir J 2003; 22: Suppl. 45, 468s Year: 2003
Rate of FEV1 decline by FEV1 percent predicted in UPLIFT® and TIOSPIR® Source: International Congress 2016 – Pharmacological management of COPD Year: 2016
Static hyperinflation and respiratory disability were associated with frequent-exacerbation phenotype in patients with severe COPD Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016
Evaluation of inspiratory flow rates in stable severe COPD patients Source: Annual Congress 2010 - Respiratory muscle function and training in acute and chronic respiratory disease Year: 2010
Oxygen desaturation events and pulmonary artery pressure in stable, moderate-severe COPD patients without respiratory failure at rest Source: Eur Respir J 2002; 20: Suppl. 38, 97s Year: 2002
Regular follow-up in severe asthma may reduce the rate of exacerbations and the FEV1 decline Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011
Changes in lung function in patients with acute COPD exacerbations: spirometry vs. forced oscillations Source: Eur Respir J 2001; 18: Suppl. 33, 149s Year: 2001
Improvement in FEV1 after acute COPD exacerbations are driven more by changes in hyperinflation than changes in proximal airway volume Source: International Congress 2015 – Clinical physiology: from airways, lung and respiratory muscles to dyspnoea in health and disease Year: 2015
Forced inspiratory volume in one second (FIV1 ) in the assessment of reversibility of airway obstruction in patients with chronic obstructive pulmonary disease (COPD) and in relation to the severity Source: Eur Respir J 2002; 20: Suppl. 38, 300s Year: 2002
Time required for PaO2 equilibration in patients with severe COPD Source: Annual Congress 2011 - COPD management Year: 2011